Catalyst Wire Dossier Catalyst Wire Dossier

Karinat

· Institute for Atherosclerosis Research
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Karinat, covering 2012-12-06 to 2012-12-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women [Phase 3]

See pricing